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Background: Biobanks (biorepositories) were established to compile collected bio-specimens 
for future research and usage. The collection/storage of bio-specimens triggers several social, 
legal, and ethical implications where public attitudes can represent the core measurement/param-
eter in defining the most acceptable practices and ethical approaches when dealing with biobanks.
Aim: The aim of this study was to explore and understand population’s perspectives, expecta-
tions, and concerns toward biobanks in Jordan.
Methods: A cross-sectional survey that included closed-ended questions was distributed among 
Jordanians. A total of 500 participants who are representative of the Jordanian population were 
included in this study.
Results: There was overwhelming support (>85%) for the establishment of biobanks in Jordan, 
and most of the participants agreed on the importance of biobanks and samples’ donation for 
promoting medical research. Enthusiasm in biobanking participation was associated with the 
sociodemographic characteristics of participants including age, educational level, and previous 
knowledge of biobanks. Moreover, considering sample donation as a religiously good deed 
appeared to have the strongest positive correlation with willingness to donate bio-specimens 
for future research. Also, participants’ trust in medical and research services, especially the 
protection of their privacy and confidentiality, was the most critical concern when they decided 
to participate in biobanks.
Conclusion: Population’s attitude toward biobanks in Jordan was positive and promising, and 
can encourage the future establishment of different biobanks. It is also necessary to take into 
consideration certain sociodemographic characteristics when discussing specific information 
with potential biobanks’ donors.
Keywords: biorepositories, sample storage, sample donation, sample reuse, ethics
Introduction
The availability of bio-specimens and their corresponding information is a core demand 
for conducting biomedical researches. In the last century, these specimens or informa-
tion used to be collected independently for each study. This approach increased the 
duration, cost, and the effort to conduct clinical studies. Moreover, such limitations 
sabotage the researchers’ ability to conduct large and high-throughput representative 
studies, either locally or at the international level.1,2
Biobanks, as public biorepositories for global research, were widely developed at 
the end of the last century (1990) to compile collected de-identified bio-specimens.3 
These biobanks were able to provide researchers with a massive genomic and pheno-
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typic database, representative of many people from extensive 
geographical areas.3,4 Recent advances in biomedical tech-
nologies and in understanding of the human genome advocate 
the value of conducting research on stored bio-specimens 
and their related health information.5 Biobanks can help in 
the progression of medical research and enable performing 
a number of studies and samples on many complex diseases 
with the ability of conducting genetic analysis in light of the 
demographic, environmental, medical, and ethnic records.6 
Obtaining sufficient and representative samples for genome-
wide association studies or screening studies for lethal and 
disabling conditions/biomarkers, especially in infants, would 
be impossible without the development of biobanks.7–10 
Moreover, this knowledge can be clinically translated and 
can practically help as diagnostic and therapeutic tools in 
what is recently called “precise or personalized medicine.”11,12
Ultimately, biobanks’ applications are significantly 
improving the public health sector.
Despite that and due to the evolving nature of biobanks, 
the collection and storage of bio-specimens triggered several 
social, legal, and ethical implications.13 In general, biobanks 
amended the general ethical concepts from individualist ethi-
cal approaches to public health ethical approaches, where the 
focus is on overall public values, attitudes, perspectives, and 
acceptance of any approach. This carried a huge debate and 
ethical concerns. Among them are privacy and confidential-
ity of personal information,14,15 research autonomy,16 open 
consent model, sharing research results or incidental findings 
with participants,17 and the possible usage and benefits from 
these samples when they are used by specific companies to 
develop products or services.18 Thereafter, public attitudes 
toward the idea of biobanks can represent the core measure-
ment/parameter in defining the most acceptable practices and 
ethical approaches when dealing with biobanks. Neverthe-
less, biobanks can also be accompanied by multiple concerns, 
which can be carried out by the individual donors themselves. 
Unfortunately, the willingness to donate bio-specimens for 
future research can be affected by these concerns especially 
in countries where cultural and religious beliefs can affect 
people’s choices and decisions.19 Therefore, the perception 
of biobanks should be clarified and considered carefully for 
different ethnicities and cultural backgrounds.
Several studies have investigated the participants’ pref-
erences regarding storage/reuse of collected bio-specimens 
especially with the recent interest in developing biobanks 
around the world.20–25 In November 2011, King Hussein 
Cancer Center Amman, Jordan announced the establishment 
of a cancer biobank for Jordan and neighboring countries.26 
Deliberation of best practices is necessary to enhance recruit-
ment efforts and public support for such projects. Therefore, 
the aim of this study was to explore and understand popula-
tion’s perspectives, expectations, and concerns toward bio-
banks in Jordan. The current results are expected to help in 
enhancing recruitment efforts and to establish new policies 
to promote scientific research while taking into consideration 
participants’ rights.
Methodology
Study design and study population
This study was approved by our local institutional review 
board committee at King Abdullah University Hospital 
under the approval number (34-105-2017). The study con-
sisted of a cross-sectional survey that included closed-ended 
questions. The distributed questionnaire was in written in 
Arabic. Participants’ attitudes were measured on a 5-point 
Likert scale with scores ranging from “strongly agree” to 
“strongly disagree.” The questionnaire was developed in 
English and was translated to Arabic, and it was pilot tested 
to ensure that the questions and the language that was used 
were comprehensible and clear to the participants. It was 
validated by four experts in bioethics including epidemiolo-
gists, statisticians, scientists, and a bioethics philosopher. 
The questionnaire was modified based on the pilot testing 
and expert feedback. It was then distributed online using 
Google forms between May and June 2017. The question-
naire was collected from 500 participants aged ≥18 years 
reflecting the socioeconomic and demographic distribution 
of Jordanian people. An informed consent form was pro-
vided to the participants before they started answering the 
questionnaire. Participants’ informed consent was obtained 
by pressing the send button at the end of the questionnaire. 
No identifying personal information was obtained from the 
participants.
Questionnaire backbone and main 
domains
The questionnaire consisted of three major domains: 1) 
demographic and socioeconomic characteristics; 2) par-
ticipants previous research experience; and 3) participants 
perspectives toward participation in biobanks and storage 
of their samples.
A short paragraph was included before the last two 
domains to help increase the knowledge of participants in 
each specific subject, since it was indicated earlier after the 
pilot testing and from previous studies conducted in Jordan 
Pharmacogenomics and Personalized Medicine 2019:12 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
25
Makhlouf et al
that a large percentage of participants had no previous 
research experience and acknowledged that they have no 
prior knowledge about biobanks.
The following information was provided to the partici-
pants before they answered the questions about their previous 
research experience.
Research is an investigation conducted to discover new facts 
or to get additional information about a certain disorder; by 
collecting then conducting experiments on biospecimens 
such as blood, urine, hair, nails, or body tissue removed 
after surgery, or by collecting information either from health 
records or questionnaires.
Scientific research also includes drug response trials 
in which patients’ response to a specific drug or treatment 
is evaluated.
After finishing this section, participants were asked about 
their attitudes toward biobanking and bio-specimens’ dona-
tion for future research. The following paragraph preceded 
these questions.
Biobank is an organized repository in which donated 
biospecimens are stored in. The compiled biospecimens 
are usually linked to the donor’s health information and 
personal information, biobanks support unlimited number 
of studies, especially genetic research.
Biobanks operate under strict privacy and confiden-
tiality measures to ensure protection of donor’s personal 
identifying information; all personal identif iers are 
encrypted using codes to make it impossible to identify 
the identity of the donor. These codes are kept in closed 
and safe place, only specified personnel can access. Any 
research team intending to use these samples in research 
will not have (code) that links samples to identifying per-
sonal information.
Statistical analysis
Data were analyzed using the SPSS® software version 21 
(IBM Corporation, Armonk, NY, USA) for Windows. Simple 
descriptive statistics were used to report participants’ char-
acteristics, frequencies, and percentages. Cross-tabulation 
(Pearson’s chi-square) was used to assess the relationship 
between attitudinal statements, demographics, and socio-
economics, participants’ earlier knowledge about biobanks, 
and participants’ previous participation in research. The 
correlations between responses within each statement and 
the overall willingness to participate in biobanking for future 
research were assessed by calculating Spearman Rho cor-
relation coefficient.
Results
Demographics and participants’ 
characteristics
Surveys were collected electronically from 500 participants; 
24 questionnaires were excluded from the analysis as they 
were not filled completely. Table 1 shows the demographics 
and socioeconomic characteristics of the respondents. The 
study sample had almost equal proportions with respect to 
gender; females (52%, n=248) and males (48%, n=228). The 
majority of respondents (59%, n=281) were between 18 and 
29 years, and about 19.5% (n=93) were between 30 and 39 
years, while 21.5% (n=58) were above 40. These percentages 
correspond to Jordanians’ demographic distribution favoring 
younger ages. A large proportion of respondents (67%) held 
an undergraduate degree, while slightly more than a quarter 
of the respondents held graduate degrees, and around 7% 
(n=35) had an education level of high school or less.
Participants’ previous research 
experience
Regarding previous research participation (Table 2), around 
50% of respondents never participated in research before this 
study, while 46% participated, and 3.6% of the participants 
stated that they were offered participation in a research study 
but refused.
When participants were asked to assess their knowl-
edge about biobanks, 60% of participants estimated their 
Table 1 Demographics and socioeconomic characteristics of the 
study population
Characteristics Count
(n=476)
%
gender Female 248 52
Male 228 48
Age (years) 18–29 281 59.0
30–39 93 19.5
40–49 44 9.2
Over 50 102 21.5
education level
(degree)
high school or less 33 7.0
Undergraduate 310 67.3
graduate 122 25.7
residence Village 104 22.3
City 268 57.5
capital 94 20.2
Monthly income
(JOD)
<500 207 44.1
500–1,000 151 32.2
>1,000 111 23.7
Abbreviation: JOD, Jordanian Dinar.
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knowledge as low, nearly 35% estimated their knowledge as 
medium, and only 5% estimated their knowledge as high. 
Further analysis showed significant association between 
higher level of education with better prior knowledge about 
biobanks (χ²=15.208, P=0.004) and previous participation 
in research (χ²=16.719, P=0.002).
Participants’ perception toward 
biobanking and bio-specimens donation 
for research
Table 3 shows participants’ attitudes toward biobanking 
and bio-specimens donation for future research. There was 
overwhelming support (>85%) for the establishment of bio-
banks in Jordan, and most of the participants agreed on the 
importance of biobanks and sample donation in promoting 
medical research. This positive view showed strong statisti-
cally significant association with higher prior knowledge 
about biobanks (χ²=19.2, P=0.004). Regarding sample 
donation for research, 85% of respondents expressed their 
willingness to donate bio-specimens for biomedical research 
whereas 79% expressed their willingness to store/reuse these 
bio-specimens for future research. Similar to the importance 
of biobanks and samples’ donation, there was a statistically 
significant association between participants’ agreement 
with the latter statement “store/reuse of bio-specimens for 
future research” and high prior knowledge about biobanks 
(χ²=18.1, P=0.02).
The overall percentage of participants’ attitudes toward 
participation in biobanking/sample donation for future 
research is shown in Figure 1. The most agreed on state-
ments, which would positively affect respondents’ willing-
ness to participate in research, were presence of strong 
privacy and confidentiality measures (97%), contribution 
to the development of society and knowledge, and helping 
individuals suffering from a certain illness (95%). This was 
followed by considering sample donation as a religiously 
good deed and it was agreed on by about three-quarters of 
the participants. There was no statistically significant asso-
ciation between the previous statements and demographics. 
On the other hand, the least agreed on statements were 
participation to get material returns (22%) and participa-
tion to get free medical tests or medications (34%). Further 
analysis showed no significant association between the 
latter statement and the income of participants; however, 
it was statistically significant with lower education level 
(χ²=30.058, P<0.01), with no previous research participa-
tion (χ²=16.396, P=0.03), and being a female (χ²=10.058, 
Table 2 Participants’ previous research experience and knowledge
Participants’ characteristics Prior participation in research Prior knowledge about biobanks
Yes No Refused P-value Low Medium High P-value
accumulative % 46.4 50 3.6  59.5 35.8 4.7  
gender Female 45.1 51.2 3.7 0.781 57.9 36.4 5.8 0.487
Male 48.2 48.6 3.2 61.3 35.1 3.6
Age (years) 18–29 41.9 53.4 4.7 0.099 59.4 37.3 3.3 0.138
30–39 53.8 44.1 2.2 65.2 27.2 7.6
Over 40 52.7 46.2 1.1 53.7 40.0 6.3
Education level (degree) high school or less 25.0 75.0 0.0 0.002a 82.1 14.3 3.6 0.004a
Undergraduate 43.7 52.2 4.1 58.1 39.0 2.9
graduate 59.7 37.8 2.5 58.0 32.8 9.2
residence Village 49.0 47.1 3.8 0.867 64.4 31.7 4.0 0.113
City 45.7 51.7 2.6 59.7 36.9 3.4
capital 46.2 49.5 4.3 53.8 36.6 9.7
Monthly income (JOD) <500 41.4 55.7 3.0 0.238 62.7 34.8 2.5 0.181
 500–1,000 50.0 45.3 4.7 58.1 37.2 4.7
 >1,000 53.7 43.5 2.8 54.1 37.6 8.3
 n=476       
Note: aP<0.05.
Abbreviation: JOD, Jordanian Dinar.
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P=0.03). Trust was also among the most agreed on state-
ments that affected participation positively, and it showed 
strong statistically significant association with participants 
over 40 years.
When participants were asked about their concerns 
over participation in biobanking (Figure 2), fear of sample 
exploitation by governmental and commercial bodies was the 
most agreed on statement (70%). This was followed by fear 
of using samples in religiously prohibited research (>65%). 
The latter statements showed statistically significant associa-
tion with younger participants (χ²=10.058, P=0.03), followed 
by factors related to privacy and confidentiality. Fear of the 
negative effects of research on privacy and confidentiality 
was agreed on by 45% of participants. This showed statisti-
cally significant association with higher education level 
(χ²=23.525, P=0.024) and previous refusal to participate in 
research (χ²=16.396, P=0.03), followed by fear of disclosure 
of stigmatizing information which was agreed on by 45% of 
participants (Figure 2). High prior knowledge of biobanks 
showed statistically significant association with the latter 
statement (χ²=10.058, P=0.03).
Correlation of several factors with 
willingness to donate bio-specimens for 
reuse in future research
To determine which factors correlate with the participants 
willingness to store their donated bio-specimens for future 
research (participation in biobanking) and to determine the 
type of relationship impact on participants’ decision (as 
Table 3 Participants attitudes toward sample donation and biobanking
Biobanks have an 
important role in 
promoting medical 
research
You might donate 
bio-specimens for 
research
Have you been asked 
to store donated bio-
specimens for future 
research
I support the 
establishment of 
biobanks
accumulative % 87.1 84.9 79 90
gender Female 90.2 86.9 83.2 92.2
Male 83.4 83.4 76.1 88.8
Age (years) 18–29 92.2 83.4 80.2 89.6
30–39 82.1 84.9 76.3 88.1
Over 40 87.1 90.4 82 95.7
Education level (degree) high school 85.7 85.7 75 85.8
Undergraduate 89 84.9 81.3 90.1
graduate 82.3 85.6 76.6 92.5
residence Village 79.8 82.7 73.8 87.3
City 87.9 85.7 81.4 92.6
capital 92.6 86.2 82.6 89.2
Income (JOD) <500 86.7 86.2 81.6 90.1
500–1,000 85.3 82.7 80 89.3
>1,000 90.7 86.1 76.1 92.7
Prior participation in research Yes 84.8 86.2 79.3 91.7
no 89.2 85.7 80.1 90.4
Refused 87.6 62.6 81.3 81.3
Knowledge of biobanks low 85 83.2 77.4 89.8
Medium 89.2 87.3 82.6 91.5
high 95.4** 90.9 85.7* 90.5
Note: *χ²=19.2, P=0.004; **χ²=18.1, P=0.02.
Abbreviation: JOD, Jordanian Dinar.
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having a positive or negative effect), Spearman’s Rho correla-
tion coefficient was used upon ranking positively influential 
statements (Table 4). Considering sample donation as a good 
deed in religion had the strongest correlation with willing-
ness to store/reuse donated specimens for future research 
(rs
s
=0.474, P<0.001). This was followed by high level of 
trust toward biomedical research and researchers (rs
s
=0.465, 
P<0.001), the availability of the consent process (rs
s
=0.352, 
P<0.001), and the willingness to help individuals suffering 
from an illness (rs
s
=0.325, P<0.001). Moreover, willingness 
to donate bio-specimens for storage/reuse for future research 
also had positive but weak statistically significant correlation 
with obtaining material returns (rs
s
=0.162, P<0.01), avail-
ability of test results (rs
s
=0.165, P<0.01), obtaining free 
tests/medication (rs
s
=0.147, P<0.01), and with the presence 
of strong measures to ensure privacy and confidentiality 
Figure 1 Jordanians’ attitudes toward participation in biobanking: encouraging factors.
Obtain material returns
Get free tests and medications
Availability of test results
Availability of consent process
Sample donation is considered a good deed in my religion Row
Strongly disagree
Disagree
Neutral
Strongly agree
Agree
I trust biomedical research and researchers
Presence of strong privacy and confidentiality measures
Having the right to withdraw my consent any time regarding the
stored samples
Because of the information provided about the importance of the study
To help people with a particular illness
Contribute to the development of society and knowledge
0 20 40 60
Values
80 100
Figure 2 Jordanians’ attitudes and fears toward participation in biobanking: discouraging factors.
Fear of sample exploitation
Fear of using samples in research prohibited by religion
Fear that trials might reveal stigmatizing information about me or my family
Fear that trials could possibly reveal my susceptibility to develop a
serious disease in the future
Unclear research procedure
No direct benefits for me
No time to participate
Fear of negative impact of research on the privacy and confidentiality
0 20 40 50
Row
Strongly disagree
Disagree
Neutral
Strongly agree
Agree
Values
60 100
I do not feel comfortable conducting experiments on my bio-specimens
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(rs
s
=0.134, P<0.01). Agreement to donate samples for stor-
age/reuse for future research also had weak statistically 
significant negative correlation with the participant not 
being comfortable conducting experiments on his samples 
(r
s
=−0.198, P<0.001), high prior knowledge about biobank 
(r
s
=−0.126, P<0.001), fear of negative effects on participant’s 
privacy and confidentiality (r
s
=−0.124, P<0.01), and unclear 
research procedure for participants.
Discussion
The current study provides some insight on Jordanians’ per-
ception toward an important aspect for advancing biomedical 
research, which is the willingness to donate bio-specimens 
for future research. Current results are representative of Jor-
dan’s general population and were not restricted to specific 
research subgroups or patients. Moreover, the results may 
be of importance to neighboring countries due to sharing of 
some of the cultural and social backgrounds.
As demonstrated by the current results, Jordanians have a 
positive view toward research even though they did not seem 
very knowledgeable about biobanks before the start of the 
study. About 60% of participants estimated their knowledge 
as low and about half of them had never participated in 
research before. However, 87% of participants acknowledged 
the importance of biobanks in promoting medical research 
and 90% supported the establishment of such projects in 
Jordan.
When participants were asked if they would donate their 
bio-specimens for future research, 79% of them agreed or 
strongly agreed with this idea. It is noteworthy that wide-
spread willingness similar to that recorded in the current 
study was observed in previous studies performed in the 
USA,20 UK,21 Sweden,22 and Uganda.23 In those studies, >80% 
of the respondents were willing to donate their bio-specimens 
for future research. On the other hand, this study showed 
either lower or higher percentages of agreement to donate 
bio-specimens for future research in comparison with other 
countries. For instance, in the UAE, >95% of respondents 
were willing to donate bio-specimens for future research.24 
In Egypt,25 only 63% of participants were enthusiastic about 
donating bio-specimens for future research. Interestingly, 
those differences do exist even though both UAE and Egypt 
are countries with relatively similar cultural, traditional, and 
religious backgrounds to Jordan. This can indicate to the dif-
ferences in research and medical environments and previous 
population experiences among those countries. This may 
also reflect differences in studies’ designs among different 
research groups. In Jordan, perspectives toward donating 
bio-specimens for biobanks were previously reported among 
multiple sclerosis and dental patients.27,28 Only one study has 
Table 4 Correlation of different factors with the willingness of participants to donate bio-specimens for future research
Factors that positively correlate with willingness to 
donate samples for storage/reuse in future research#
rs
(p)
Factors that negatively correlate with willingness to 
donate samples for storage/reuse in future research #
rs
(p)
Sample donation is considered a good deed in your religion 0.474** I do not feel comfortable conducting experiments on me or 
on samples that belong to me
–0.198**
Trust biomedical research and researchers 0.465** high prior knowledge about biobank
Fear of the negative effects on my privacy and confidentiality
0.126**
0.124*
Biobanks have an important role in promoting medical 
research
0.411** No direct benefits form participation –0.117*
Help people suffering from an illness 0.325** research procedure is unclear –0.106*
Availability of consent process 0.352** Factors that do not correlate with willingness to 
donate samples for storage/reuse in future research
rs
(p)
Because of the information provided about the importance 
of the study
0.324** i do not have time to participate 0.011
(0.817)
Contribute to the development of society and knowledge 0.292** Future studies could reveal stigmatizing information 0.059
(0.206)
Obtain material returns for participation 0.162** Fear of using samples in religiously prohibited research 0.063
(0.178)
Availability of test result 0.156* Fear of sample exploitation by commercial and governmental 
bodies
0.007
0.841
To get free tests and medications 0.147*
Measures to ensure privacy and confidentiality 0.134*
Notes: #Statistically significant result. *Statistically significant result at P<0.01. **Statistically significant result at P<0.001.
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previously targeted the Jordanian general population.29,30 
Notably, the current study showed that higher percentages 
of Jordanian public are willing to donate bio-specimens for 
future research (79% vs 63.8%).29,30 This might be related 
to the sufficiency of the information provided to the par-
ticipants before they answered the corresponding questions. 
We believe that careful and documented explanations of 
biobanking acted as a modulator and shifted views in favor 
of biobanks by providing participants with assurances that 
increased their awareness and reduced their concerns over 
participation. This complies with the current hypothesis that 
education has a critical role in promoting public participation 
in biobanking.31 Moreover, our survey focused only on bio-
banks without distracting the interviewer or the interviewee 
with other aspects of medical research and without restricting 
their answers to cancer research.
When participants were asked if they would donate their 
bio-specimens for research, around 86% agreed/strongly 
agreed with the statement. Whereas when participants were 
asked if they would allow storage and reuse of the donated 
samples, almost 10% of them changed their opinion. This 
small reluctance in participation could be related to reasons 
other than sample donation itself. “I do not feel comfort-
able conducting experiments on my samples and fear of the 
negative effects on my privacy and confidentiality” showed 
the highest levels of negative correlation with willingness 
to provide bio-specimens for future research. In accordance 
with that, 97% of participants agreed on the importance 
of maintaining privacy and confidentiality of donors and 
unfortunately 45% considered fear of breaching the privacy 
and confidentiality of donors as a concern for participation 
in biobanking. This fear was associated particularly with 
older participants and those who previously refused to 
participate in research, thereafter, showed a weak negative 
correlation with the willingness to donate bio-specimens for 
future research. Based on those results, it seems that privacy 
concerns did not completely deter participants from taking 
part in research. However, it could be one of many factors 
that participants may take into consideration when deciding 
to participate in biobanking.
It is also interesting to note that higher knowledge of 
biobanks correlated negatively with the willingness to donate 
bio-specimens for future research. This contradicts the results 
obtained by Goddard et al in 2009,32 where participants who 
had higher knowledge about biobanks were more willing to 
participate in biobank-related activities. To explain these 
results, it is possible that participants with high knowledge 
of biobanks can determine potential pitfalls of biobanking 
on autonomy, privacy, and confidentiality of participants 
and this could, in turn, deter them from sample donation. In 
agreement with that, fear of sample exploitation and fear of 
using collected samples in religiously prohibited research 
were among the most agreed on concerns over participation in 
research, particularly among younger participants. However, 
we found no statistically significant correlation between the 
latter concerns and willingness to donate bio-specimens for 
future research/biobanks. On the other hand, considering 
sample donation as a religiously good deed appeared to have 
the strongest positive correlation with willingness to donate 
bio-specimens for future research. This result disagreed with 
other previous studies where the perception of respondents 
to research was negatively affected by presumed religious 
beliefs.32
Another interesting aspect, when comparing between dif-
ferent studies, is the importance given to the effect of trust on 
enthusiasm to participate in biobanking. In this study, trust 
appeared to act as a major influencing factor, which can affect 
the aforementioned aspects of research. Trust is an integral 
part for advancement of biomedical research.5,34,35 Numerous 
studies reported a positive correlation between the level of 
trust and individuals’ readiness to donate bio-specimens.29,35,36
Limitations
The response rate in this study cannot be calculated given 
that the recruitment method depended on social media 
network to cover a diverse population in the community 
and to collect responses from different geographical areas 
in Jordan. Also, we relied on participants’ self-reported 
attitudes and hypothetical scenarios, rather than actual 
behaviors. The design of the current study may have possibly 
excluded some valid participants who are less educated, 
elderly, rural, and others who are less likely to be engaged 
with social media. However, unlike other countries and 
according to unofficial websites, in Jordan >70% of the 
population have social media accounts. Moreover, it is 
worth mentioning that according to the Jordanian culture, 
opinions of the educated and young family members are 
well respected by the other members (elderly and less edu-
cated) and may have high influence on their choices in many 
aspects of their lives including their decision on donating 
bio-specimens for biobanks.
Given that this is an online survey provided to the gen-
eral population, the true responses and the accuracy of the 
reported information cannot be verified.
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Conclusion
The enthusiasm to participate in biobanking was associated 
with sociodemographic characteristics of participants particu-
larly with age, educational level, and previous knowledge of 
biobanks. Trust in medical and research services, especially 
protection of participants’ privacy and confidentiality, is critical 
when there is support to participate in biobanks. Accordingly, 
it is necessary to take into consideration those factors that 
emerged from our study when discussing specific informa-
tion with potential biobanks’ donors. The population attitude 
toward biobanks in Jordan was positive and promising, and 
can encourage the future establishment of different biobanks.
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